Sponsor:
The California Medical Innovations Institute, Inc.
Code:
NCT05412069
Conditions
Normal Subjects
Fecal Incontinence
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Fecobionics
Brief summary:
Conditions
Normal Subjects
Fecal Incontinence
Study ID
NCT05412069
Start date
Feb 15, 2023
Status verified date
Oct, 2025
Completion date
Mar 31, 2027
Anticipated
Primary completion date
Dec 1, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
155 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Basic Science
Arms
experimental: Fecobionics study
active comparator: Feco BFT
Interventions
Fecobionics
Primary outcome measure
Central contacts
Locations
Augusta University Medical Center
Recruiting
Augusta, Georgia, United States, 30912
Contacts
Sponsor
The California Medical Innovations Institute, Inc.
Last update posted
Oct 21, 2025
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The California Medical Innovations Institute, Inc. on 2025-10-21.